Eroxon® is now available to men with ED and their partners in 27 countries worldwide, including in the USA, Mexico, throughout most of Europe and a number of countries in the Middle East.
As with any new product launch in any category, the launch of a brand-new consumer product, in a brand-new category which requires new consumer behaviour and education, takes time.
As a fast-acting, topical treatment available over the counter, Eroxon® can be used in the moment and integrated into intimacy, including as part of foreplay. Positioned as a first-step, particularly for men with mild to moderate or occasional ED, Eroxon® occupies a distinct space in the category - bridging efficacy, spontaneity, and a more experience-led approach to sexual health.
We are actively exploring opportunities to optimise performance in our existing markets and expand into the Asia-Pacific region where considerable interest has been expressed by potential commercial partners.